Home / English / Adolescent kidney transplant
Category: Nephrology · Pediatric & adolescent transplant · DDKT
Adolescent Deceased-Donor Kidney Transplant: Graft Reperfusion, DGF, Immunosuppression, and Medication Adherence
Adolescent deceased-donor kidney transplant reconnects donor vessels to the pelvis. Early delayed graft function from ischemia-reperfusion is common and often recovers with support. Care centers on exact-time immunosuppression, intake–output logging, infection precautions, and urgent contact for fever or falling urine output.
Critical warning signs (Red Flags)
Contact the transplant center or emergency care immediately for any of the following:
- High fever, chills, or a rapid overall decline
- Pain, tightness, swelling, or redness over the iliac fossa graft wound
- A sharp drop in urine output, or nearly empty catheter drainage
- Pitting leg edema, rapid weight gain, or unusual breathlessness
- Blood pressure much higher than the person’s usual readings, with severe headache
- Repeated vomiting of doses, or several missed immunosuppression doses without telling the team
These signs can track rejection, infection, surgical complications, or missed medicines — do not wait them out at home.
What families often worry about
After months on the waiting list, a call to surgery brings hope and fear together: Will the new kidney work right away? How intense will immunosuppression be? How can a teenager return to school without excess infection or rejection risk?
1. Graft reperfusion and delayed graft function (DGF)
After vascular anastomosis, blood re-enters the donor kidney (graft reperfusion). The graft may pink up and start filtering, yet deceased-donor kidneys often carry cold-ischemia time, so ischemia-reperfusion injury (IRI) and delayed graft function (DGF) remain common early issues.
Sort kidney-layer warning signals
Review severity banding and receive personalized guidance from our Advisory team
2. Early immunosuppression and adolescent adherence
Perioperative care often includes induction immunosuppression to blunt early immune attack on the graft, then maintenance drugs such as a calcineurin inhibitor (tacrolimus), an antimetabolite (mycophenolate mofetil), and corticosteroids per center protocol — exact agents and doses belong only to the treating clinicians.
Practical adolescent adherence steps
- Use the same clock time daily with shared alarms during the transition to self-care
- Use a weekly pill organizer and carry spare doses when leaving home
- Do not stop or change doses when feeling better, or for side effects, without contacting the team
- Call promptly after vomiting doses, or before starting interacting medicines
Adolescent post-transplant recovery timeline
Phase, graft physiology, medicines/labs, and family role
| Phase | Graft & physiology | Medicines & labs | Family role |
|---|---|---|---|
| Surgery day–72 h | Reperfusion; urine may be prompt or delayed | Induction; watch hemodynamics / urine | Stay close to clinicians; note symptoms day by day |
| Weeks 1–2 | DGF common after DDKT; supportive dialysis possible | Titrate immunosuppression; creatinine / trough | Log intake–output; dose on time |
| Months 1–3 | Function often improves; immune suppression still high | Infection prophylaxis; CMV/BK surveillance | Masks, hand hygiene, limit crowds |
| After 3 months | Aim for stable graft plus age-appropriate growth | Taper intensity per clinicians; clinic visits | Hand adherence skills to the adolescent stepwise |
3. Infection precautions and growth after transplant
Early immunosuppression raises bacterial, viral, and opportunistic infection risk. Pediatric transplant programs therefore emphasize viral surveillance such as CMV and BK polyomavirus on a center schedule.
Home practices that help
- Wash hands before medicines/meals and after toileting
- Mask in crowded indoor spaces in the early months as advised
- Choose thoroughly cooked, freshly prepared food; avoid uncertain water sources
- Report fever, lingering cough, dysuria, or unusual fatigue promptly
Catch-up growth
When graft function improves, many children and adolescents grow better after pre-transplant uremia. Outcomes still vary with age, steroids, and nutrition — not a promise for every recipient — so height and weight tracking remains part of follow-up.
Post-op care checklist for families
Domain, daily log, usual targets, and crisis cues
| Domain | Daily log | Usual target | Crisis cue |
|---|---|---|---|
| Intake–urine | Drink volume and urine/catheter output | Targets set by the transplant team | Rapid oliguria |
| Immunosuppression | Time each dose was taken | Same daily clock ± allowed window | Missed doses / vomited doses |
| Wound & symptoms | Pain, swelling, redness, fever | Pain easing day by day | Tense graft-site swelling or fever |
| Mobility | Light walking when cleared | Lower venous-thrombosis risk | One-sided leg swelling, calf pain |
Safer practices versus hazards after kidney transplant
Recommended habits versus high-risk behaviors
| Domain | Do | Avoid | Why |
|---|---|---|---|
| Immunosuppression | Dose on time; trough labs as scheduled | Stopping medicine because you feel well | Rejection risk / level swings |
| Infection | Hand hygiene; masks per team plan | Close contact with febrile people unprotected | Early immune suppression |
| Food / herbs | Ask before supplements | Self-starting strong CYP3A4 inducer herbs | May alter tacrolimus exposure |
| Activity | Light walking when cleared | Heavy lifting before clearance | Wound and hemodynamics still fragile |
4. Rejection cues and home monitoring after discharge
After discharge, centers usually check labs often for creatinine and drug levels. A rising creatinine with oliguria, edema, or fever warrants same-day contact — do not wait for the next routine visit if the pattern changes sharply.
Frequently asked questions (FAQ)
What happens physiologically during deceased-donor kidney transplant in an adolescent?
Surgeons connect the donor kidney artery and vein to pelvic vessels in the recipient. When clamps are released, blood reperfuses the graft. Urine may start immediately or more slowly depending on ischemia-reperfusion injury severity.
What causes delayed graft function (DGF) and how is it managed?
DGF often follows cold ischemia and ischemia-reperfusion injury, so tubules work slowly for a while. Clinicians may use temporary dialysis while watching urine output, creatinine, and hemodynamics until recovery — this is not the same as immediate permanent graft loss.
How can families build adolescent immunosuppression adherence?
Use a fixed daily schedule, shared reminders between caregivers and the adolescent, a medication log, and on-time tacrolimus trough checks. Missed or self-adjusted doses raise drug-level variability and late rejection risk in adolescents.
How should infection risk be reduced in the first 1–3 months?
Mask in crowded indoor spaces as advised, wash hands often, eat thoroughly cooked freshly prepared food, avoid people with contagious illness, take prophylaxis per center protocol, and complete CMV/BK surveillance labs on schedule.
Which red flags suggest rejection or early surgical complications?
High fever with chills, tender swelling over the iliac fossa graft site, a sharp drop in urine output, pitting leg edema, unusual blood-pressure rise, or a creatinine jump from baseline — contact the transplant center promptly.
Why is medication non-adherence more common in adolescents?
Adolescence is a transition from caregiver-led care to self-management. School schedules, peers, and body-image concerns can interrupt dosing. AYA research therefore emphasizes shared reminders, clear role splitting, and close trough monitoring.
Can growth improve after a successful kidney transplant in teenagers?
Many recipients show catch-up growth once uremia improves, but results vary with age at transplant, pre-transplant uremic duration, steroids, and nutrition — not a promise for every child, and height/weight still need clinic follow-up.
Can the website score replace a transplant clinic visit?
No. The score helps organize warning signals before you talk with the transplant center. It does not diagnose DGF or rejection and does not authorize self-adjustment of immunosuppression.
Scientific mechanism (author summary)
By Asst. Prof. Dr. Norawit Raatpiboon: Cold ischemia plus reperfusion generates reactive oxygen species and endothelial swelling in tubules, producing acute tubular injury and frequent DGF after DDKT. Recipient immunity still recognizes graft antigens, so induction and maintenance immunosuppression are required. In adolescents, irregular dosing widens tacrolimus intra-patient variability and links to late antibody-mediated rejection risk. Viral surveillance and infection precautions therefore travel with adherence discipline — which is why families should treat DGF as a support window rather than permanent failure, and treat adherence as a long-horizon driver of graft survival.
E-E-A-T and academic citations
- Yarlagadda SG, et al. Association between delayed graft function and allograft and patient survival: a systematic review. Nephrol Dial Transplant 2009. PMID 19103734
- Yarlagadda SG, et al. Marked variation in the definition and diagnosis of delayed graft function. Nephrol Dial Transplant 2008. PMID 18408075
- Siedlecki A, et al. Delayed graft function in the kidney transplant. Am J Transplant 2011. PMID 21929642
- Eltzschig HK, Eckle T. Ischemia and reperfusion—from mechanism to translation. Nat Med 2011. PMID 22064429
- Nguyen C, et al. Promoting medication adherence from the perspective of adolescent and young adult kidney transplant recipients. Pediatr Transplant 2020. PMID 32388916
- Dabirzadeh A, et al. Care processes and structures associated with higher medication adherence in adolescent and young adult transplant. Pediatr Transplant 2021. PMID 34339090
- Vaisbourd Y, et al. Differences in medication adherence by sex and organ type among adolescent and young adult solid organ transplant recipients. Pediatr Transplant 2023. PMID 36478059
- Abu-Ghanam H, et al. Linear growth in pediatric kidney transplant recipients. Pediatr Nephrol 2026. PMID 42557503
- Elamin M, et al. Growth in Children After a Kidney Transplant. Cureus 2024. PMID 39385853
- Smith JM, et al. Viral surveillance and subclinical viral infection in pediatric kidney transplantation. Pediatr Nephrol 2015. PMID 25125226
- Kasiske BL, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int 2010. PMID 19847156
Medical disclaimer
This article is educational only. It is not a diagnosis, immunosuppression prescription, or dialysis plan for any individual. Decisions about induction, drug levels, supportive dialysis, rejection treatment, and infection care belong with the transplant center. Seek emergency care for urgent symptoms.